Clinical Trial Update: First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide [EARLY_Phase 1]

View source ↗

Summary

First-in-human Phase 1 PET imaging study of the 18F-αvβ6-binding peptide, a radiotracer targeting αvβ6, is active but not currently recruiting for several cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Pancreatic Cancer
• Rectal Cancer

Drugs mentioned

• 18F-αvβ6-binding peptide radiotracer (18F-αvβ6-binding peptide)

Snippet

Sponsor: Julie L. Sutcliffe, Ph.D | Conditions: Breast Carcinoma, Colorectal Carcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING